Ropinirole Side Effects and Clinical Recommendations

Common Side Effects

Gastrointestinal effects, including nausea and vomiting, are among the most frequently reported side effects in patients taking ropinirole, according to the American Geriatrics Society 1
Central nervous system effects, such as somnolence, drowsiness, and headache, are common in patients taking ropinirole, as reported by the American Geriatrics Society 1
Hallucinations, particularly in older patients, are a potential side effect of ropinirole, as noted by the American Geriatrics Society 1
Orthostatic hypotension is a cardiovascular effect of ropinirole, as reported by the American Geriatrics Society 1

Compulsive behaviors, including unusual urges such as gambling, increased sexual urges, uncontrollable shopping, and compulsive eating, are a potential side effect of ropinirole, as reported by the American Geriatrics Society 1

Older patients are at particular risk for orthostasis and drug interactions when taking ropinirole, according to the American Geriatrics Society 1
Hallucinations are more common in elderly patients taking ropinirole, as noted by the American Geriatrics Society 1
Cognitive effects may be more pronounced in older adults taking ropinirole, as reported by the American Geriatrics Society 1

Augmentation is characterized by worsening and earlier onset of symptoms in patients initially controlled on ropinirole, as reported by the American Geriatrics Society 1, 3
Typical presentations of augmentation include earlier symptom onset during the day, increased symptom intensity, and spread of symptoms to other body parts, according to the American Geriatrics Society 1, 3

The American Academy of Sleep Medicine suggests against the standard use of ropinirole for restless legs syndrome, due to concerns about long-term adverse effects, with a conditional recommendation and moderate certainty of evidence 2, 4
If used for RLS, ropinirole should be reserved for patients who prioritize short-term symptom reduction over concerns about long-term adverse effects, as recommended by the American Academy of Sleep Medicine 2
The starting dose for RLS is 0.25 mg orally 1-3 hours before bedtime, as recommended by the American Geriatrics Society 1
The dose can be increased after 2-3 days to 0.5 mg, and to 1 mg after 7 days, as recommended by the American Geriatrics Society 1
Titration should proceed slowly with weekly 0.5 mg increments to a maximum of 4 mg at week 7 if needed, as recommended by the American Geriatrics Society 1

Monitor for orthostatic hypotension, especially when initiating therapy or increasing dose, as recommended by the American Geriatrics Society 1
Consider drug interactions with other medications, as recommended by the American Geriatrics Society 1